comprehensive -WSS

comprehensive

author：entertainment 2025-09-02 11:48:28 - browse：114

A man enters the Regeneron Clinic at a monoclonal antibody treatment site in Pembroke Pines, Florida – politics and policy coverage from STAT — Regeneron agreed to price limits for a new Covid-19 drug that will be developed in partnership with the Department of Health and Human Services. CHANDAN KHANNA/AFP via Getty Images

WASHINGTON — A groundbreaking clause in a new deal between the Department of Health and Human Services and the pharmaceutical company Regeneron marks the first time the Biden administration has directly used its leverage to challenge drugmakers’ list prices, experts told STAT.

The contract between Regeneron and the government requires that the list price for a future monoclonal antibody drug to prevent Covid-19 is the same or lower in the United States as in other high-income countries. The release doesn’t explain which countries the government will be comparing prices with, or how pricing data will be determined.

The deal was part of the White House’s Project NextGen initiative, which includes $5 billion in new vaccines and therapies. HHS announced that it is spending $326 million to help Regeneron develop a new monoclonal antibody to prevent Covid-19. Regeneron in January announced plans to start testing a potentially variant-proof antibody, which is set to go into clinical trials later this year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Senate panel eyes new effort on drug shortages

knowledge

WSS

When women are denied an abortion, their children fare worse than peers

FDA rejects Alnylam's heart disease treatment over insufficient data

How a key Senate committee is planning to regulate PBMs

Why age limits for politicians are a terrible idea

Bill would stop addiction treatment from triggering child abuse inquiry

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

entertainment

comprehensive

hotspot

What does generative AI mean for health care? We asked experts

Bill would stop addiction treatment from triggering child abuse inquiry

Peter Hotez and the public health issue of online harassment

Why Charlie Gard's case is so disturbing to Americans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Why Charlie Gard's case is so disturbing to Americans

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

FDA approves first blood sugar monitor without finger pricks

Continuity nursing helped my family in our darkest PICU moments

Severe heat forecast: Where scorching temperatures will persist over the next week

leisure time

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

PrEP can help anyone prevent HIV. Why do so few people take it?

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

New requirements coming in 2024 for Americans traveling to Europe

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

Malaysia cuts short music fest after British band slams anti

hotspot

knowledge

hotspot

leisure time